General
Preferred name
PD-98059
Synonyms
PD 98059 ()
PD 98,059 ()
PD98059 ()
PD-098059 ()
P&D ID
PD002681
CAS
167869-21-8
Tags
available
drug candidate
Drug indication
Cardiac arrest
Drug Status
investigational
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
PD98059 is a non-ATP competitive MEK inhibitor i.e. it acts as a negative allosteric modulator .
(GtoPdb)
DESCRIPTION
Specific inhibitor of the activation of mitogen-activated protein kinase kinase (MAPKK)
(LOPAC library)
DESCRIPTION
MEK inhibitor
(Tocriscreen Plus)
DESCRIPTION
Potent, selective inhibitor of PDGFRbeta
(Tocris Bioactive Compound Library)
DESCRIPTION
Specific inhibitor of MEK
(Tocriscreen Total)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
2
Compound Sets
19
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
Cayman Chemical Bioactives
Drug Repurposing Hub
DrugBank
DrugMAP
DrugMatrix
Guide to Pharmacology
JUMP-Target 1 Compound Set
LINCS compound set
LOPAC library
MedChem Express Bioactive Compound Library
Novartis Chemogenetic Library (NIBR MoA Box)
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
Tocriscreen Plus
Tocriscreen Total
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
34
Properties
(calculated by RDKit )
Molecular Weight
267.09
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
1
Rotatable Bonds
2
Ring Count
3
Aromatic Ring Count
3
cLogP
3.05
TPSA
65.46
Fraction CSP3
0.06
Chiral centers
0.0
Largest ring
6.0
QED
0.72
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target Type
Enzymes
Selectivity
MEK2
Pathway
MAPK
Autophagy
Immunology/Inflammation
MAPK/ERK Pathway
Stem Cell/Wnt
Target
MEK1
AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1
BRAF
Aryl hydrocarbon receptor
ERK
AhR,MEK
Primary Target
MEK
MOA
Inhibitor
ERK1 Inhibitors
MEK1 Inhibitors
MEK2 Inhibitors
MKK4 Inhibitors
MEK inhibitor
Member status
member
Source data